Menu Search
Equities

Albemarle Corp

AMC:BRN

Albemarle Corp

Actions
  • Price (CHF)90.02
  • Today's Change0.00 / 0.00%
  • Shares traded20.00
  • 1 Year change-18.29%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Albemarle Corporation is engaged in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. The Company is a global developer, manufacturer, and marketer of specialty chemicals. Its segments include Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. Its Specialties business optimizes its portfolio of bromine and highly specialized lithium solutions. Its Specialties business serves a variety of industries, including energy, mobility, connectivity, and health. Specialty products are essential in both internal combustion and electric vehicles, from high-voltage cables and powertrains to airbags and tires. Its three main product lines in its Ketjen segment are clean fuels technologies (CFT), fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS).

  • Revenue in USD (TTM)6.50bn
  • Net income in USD-1.97bn
  • Incorporated1993
  • Employees9.00k
  • Location
    Albemarle Corp4250 Congress Street, Suite 900CHARLOTTE 28209United StatesUSA
  • Phone+1 (980) 299-5700
  • Fax+1 (225) 388-7686
  • Websitehttps://www.albemarle.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.